Basclain K A, Shilkin K B, Withers G, Reed W D, Jeffrey G P
Department of Medicine, University of Western Australia, Nedlands.
J Gastroenterol Hepatol. 1998 Jun;13(6):624-34. doi: 10.1111/j.1440-1746.1998.tb00701.x.
Genetic haemochromatosis is a common iron overload disorder of unknown aetiology. To characterize the defect of iron metabolism responsible for this disease, this study localized and semi-quantified the mRNA and protein expression of transferrin, transferrin receptor and ferritin in the liver and duodenum of patients with genetic haemochromatosis. Biopsies were obtained from iron-loaded non-cirrhotic patients with genetic haemochromatotic and control patients with normal iron stores. Additional duodenal biopsies were obtained from patients with iron deficiency. Immunohistochemical and in situ hybridization analysis for transferrin, transferrin receptor and ferritin was performed. Hepatic transferrin, transferrin receptor and ferritin protein expression was localized predominantly to hepatocytes and was increased in patients with genetic haemochromatosis when compared with normal controls. Interestingly, hepatic ferritin mRNA expression was not increased in these same patients. In the genetic haemochromatotic duodenum, ferritin mRNA and protein was localized mainly to crypt and villus epithelial cells and the level of expression was decreased compared with normal controls, but similar to iron deficiency. Duodenal transferrin receptor mRNA and protein levels colocalized to epithelial cells of the crypt and villus were similar to normal controls. Early in the course of genetic haemochromatosis and before the onset of hepatic fibrosis, transferrin receptor-mediated iron uptake by hepatocytes contributes to hepatic iron overload. Increased hepatic ferritin expression suggests this is the major iron storage protein. While persisting duodenal transferrin receptor expression may be a normal response to increased body iron stores in patients with genetic haemochromatosis, decreased duodenal ferritin levels suggest that duodenal mucosa is regulated as if the patient were iron deficient.
遗传性血色素沉着症是一种病因不明的常见铁过载疾病。为了明确导致该疾病的铁代谢缺陷,本研究对遗传性血色素沉着症患者肝脏和十二指肠中转铁蛋白、转铁蛋白受体和铁蛋白的mRNA及蛋白表达进行了定位和半定量分析。从铁过载的非肝硬化遗传性血色素沉着症患者以及铁储备正常的对照患者身上获取活检组织。另外还从缺铁患者身上获取十二指肠活检组织。对转铁蛋白、转铁蛋白受体和铁蛋白进行了免疫组织化学和原位杂交分析。肝脏中转铁蛋白、转铁蛋白受体和铁蛋白的蛋白表达主要定位于肝细胞,与正常对照相比,遗传性血色素沉着症患者的表达增加。有趣的是,这些患者肝脏中铁蛋白mRNA表达并未增加。在遗传性血色素沉着症患者的十二指肠中,铁蛋白mRNA和蛋白主要定位于隐窝和绒毛上皮细胞,与正常对照相比表达水平降低,但与缺铁情况相似。十二指肠中转铁蛋白受体mRNA和蛋白水平定位于隐窝和绒毛上皮细胞,与正常对照相似。在遗传性血色素沉着症病程早期且肝纤维化出现之前,肝细胞通过转铁蛋白受体介导的铁摄取导致肝脏铁过载。肝脏铁蛋白表达增加表明这是主要的铁储存蛋白。虽然遗传性血色素沉着症患者十二指肠中转铁蛋白受体持续表达可能是对体内铁储备增加的正常反应,但十二指肠铁蛋白水平降低表明十二指肠黏膜的调节方式就好像患者缺铁一样。